The effect of social deprivation on clinical outcomes and the use of treatments in the UK cystic fibrosis population: a longitudinal study Dr David C Taylor-Robinson, MBChB, Prof Rosalind L Smyth, FMedSci, Prof Peter J Diggle, PhD, Prof Margaret Whitehead, PhD The Lancet Respiratory Medicine Volume 1, Issue 2, Pages 121-128 (April 2013) DOI: 10.1016/S2213-2600(13)70002-X Copyright © 2013 Elsevier Ltd Terms and Conditions
Figure 1 Comparison of anthropometric outcomes, by age and socioeconomic status Mean cross-sectional (A) weight, (B) height, and (C) body-mass index (BMI). The Lancet Respiratory Medicine 2013 1, 121-128DOI: (10.1016/S2213-2600(13)70002-X) Copyright © 2013 Elsevier Ltd Terms and Conditions
Figure 2 Comparison of respiratory outcomes, by age and socioeconomic status Mean cross-sectional (A) FEV1 and (B) Pseudomonas aeruginosa colonisation prevalence. The Lancet Respiratory Medicine 2013 1, 121-128DOI: (10.1016/S2213-2600(13)70002-X) Copyright © 2013 Elsevier Ltd Terms and Conditions
Figure 3 Comparison of treatment methods, by age and socioeconomic status Proportion of patients who received (A) any intravenous antibiotic treatment, (B) home intravenous antibiotic treatment, (C) hospital intravenous antibiotic treatment, (D) supplemental feeding, (E) DNase, and (F) inhaled antibiotics. The Lancet Respiratory Medicine 2013 1, 121-128DOI: (10.1016/S2213-2600(13)70002-X) Copyright © 2013 Elsevier Ltd Terms and Conditions